GottfriedEKonecnyMD
Oncology • Los Angeles, CAGynecologic Cancer
Associate Professor, Medicine, University of California Los Angeles David Geffen SOM
Dr. Konecny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Med Plz
Ste 510
Los Angeles, CA 90095Phone+1 310-794-1276- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gynecologic Oncology, 2005 - 2007
Ludwig Maximilian University of Munich Faculty of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 2013 - 2024
Clinical Trials
- Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer Start of enrollment: 2009 Jan 01
- Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer Start of enrollment: 2009 Jan 01
- Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer...Mihaela C Cristea, Daphne Stewart, Timothy Synold, Nora Ruel, Joanne Mortimer, Edward Wang, Alexander Jung, Sharon Wilczynski, Gottfried E Konecny, Melissa Eng, Lindsa...> ;Gynecologic Oncology. 2024 Mar 1
- Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival.Teresa H Kim, Mingyan Zhang, Kari Kubalanza, Charisse Liz Treece, Dana Chase, Sanaz Memarzadeh, Ritu Salani, Beth Karlan, Jianyu Rao, Gottfried E Konecny, Marsh, L.> ;Gynecologic Oncology. 2023 Oct 1
- 10 citationsStrategies for prevention and management of ocular events occurring with mirvetuximab soravtansine.Andrew Hendershot, Mark Slabaugh, Kamran M Riaz, Kathleen N Moore, David M O'Malley, Ursula Matulonis, Gottfried E Konecny> ;Gynecologic Oncology Reports. 2023 Jun 1
- Join now to see all
Press Mentions
Targeted Therapy for Early Breast Cancer and Advances in PSMA PET Scans at ASCOMay 22nd, 2023- UCLA Joins Clinical Trial to Study COVID-19 in People with CancerSeptember 15th, 2020
OncLive® Presents State of the Science Summit™ on Ovarian CancerJune 17th, 2019- Join now to see all
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
